Parainfluenza virus type 3 infections in a hematology unit View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-02

AUTHORS

U Hohenthal, J Nikoskelainen, R Vainionpää, R Peltonen, M Routamaa, M Itälä, P Kotilainen

ABSTRACT

Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295–300. More... »

PAGES

295-300

References to SciGraph publications

  • 1981-01. Persistent parainfluenza virus shedding during isolation at the South Pole in NATURE
  • 1993-09. Parainfluenza virus infection in adult bone marrow transplant recipients in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 1997-05. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections in BONE MARROW TRANSPLANTATION
  • 1988. Direct Antigen Detection in LABORATORY DIAGNOSIS OF INFECTIOUS DISEASES PRINCIPLES AND PRACTICE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776

    DOI

    http://dx.doi.org/10.1038/sj.bmt.1702776

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1026152219

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/11277177


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross Infection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Finland", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematologic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hospital Units", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunocompromised Host", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Parainfluenza Virus 3, Human", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Paramyxoviridae Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ribavirin", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hohenthal", 
            "givenName": "U", 
            "id": "sg:person.01023540424.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023540424.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nikoskelainen", 
            "givenName": "J", 
            "id": "sg:person.0623450752.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623450752.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Virology, Turku University, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.1374.1", 
              "name": [
                "Department of Virology, Turku University, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vainionp\u00e4\u00e4", 
            "givenName": "R", 
            "id": "sg:person.0612620377.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612620377.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Peltonen", 
            "givenName": "R", 
            "id": "sg:person.01342274627.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342274627.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Surgery, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Routamaa", 
            "givenName": "M", 
            "id": "sg:person.0742670020.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742670020.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "It\u00e4l\u00e4", 
            "givenName": "M", 
            "id": "sg:person.01231423755.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423755.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kotilainen", 
            "givenName": "P", 
            "id": "sg:person.01137767024.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137767024.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.bmt.1700752", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017083491", 
              "https://doi.org/10.1038/sj.bmt.1700752"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4612-3900-0_4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016607238", 
              "https://doi.org/10.1007/978-1-4612-3900-0_4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02009383", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013894701", 
              "https://doi.org/10.1007/bf02009383"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/289187a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038585061", 
              "https://doi.org/10.1038/289187a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-02", 
        "datePublishedReg": "2001-02-01", 
        "description": "Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295\u2013300.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.bmt.1702776", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1096890", 
            "issn": [
              "0268-3369", 
              "1476-5365"
            ], 
            "name": "Bone Marrow Transplantation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "27"
          }
        ], 
        "keywords": [
          "parainfluenza virus type 3", 
          "lower respiratory tract infections", 
          "respiratory tract infections", 
          "tract infections", 
          "isolation precautions", 
          "hematology unit", 
          "parainfluenza virus type 3 infection", 
          "intravenous ribavirin therapy", 
          "contact isolation precautions", 
          "Infectious Diseases Unit", 
          "type 3 infection", 
          "high mortality rate", 
          "virus type 3", 
          "PIV3 infection", 
          "intravenous ribavirin", 
          "ribavirin therapy", 
          "BMT recipients", 
          "respiratory symptoms", 
          "hematological patients", 
          "nosocomial spread", 
          "nasopharyngeal samples", 
          "Diseases Unit", 
          "nosocomial origin", 
          "chest radiographs", 
          "hematological malignancies", 
          "mortality rate", 
          "patients", 
          "early commencement", 
          "hospital hygiene", 
          "antigen detection", 
          "infection", 
          "type 3", 
          "strict adherence", 
          "rapid diagnostics", 
          "infiltrate", 
          "ribavirin", 
          "cohorting", 
          "nasopharyngeal", 
          "malignancy", 
          "therapy", 
          "symptoms", 
          "radiographs", 
          "mortality", 
          "precautions", 
          "disease", 
          "wards", 
          "recipients", 
          "adherence", 
          "further education", 
          "hygiene", 
          "spread", 
          "commencement", 
          "staff", 
          "units", 
          "period", 
          "rate", 
          "experience", 
          "diagnostics", 
          "samples", 
          "detection", 
          "education", 
          "origin", 
          "policy", 
          "spread of PIV3", 
          "PIV3-positive hematological patients", 
          "PIV3 lower respiratory tract infection", 
          "systematic nasopharyngeal", 
          "Bone Marrow Transplantation (2001) 27", 
          "Transplantation (2001) 27", 
          "virus type 3 infections"
        ], 
        "name": "Parainfluenza virus type 3 infections in a hematology unit", 
        "pagination": "295-300", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1026152219"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.bmt.1702776"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "11277177"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.bmt.1702776", 
          "https://app.dimensions.ai/details/publication/pub.1026152219"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T18:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_337.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.bmt.1702776"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'


     

    This table displays all metadata directly associated to this object as RDF triples.

    271 TRIPLES      22 PREDICATES      120 URIs      107 LITERALS      25 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.bmt.1702776 schema:about N04034540a8e84a838204243af16166c0
    2 N242fdc501c8747eeb01a37153c31c0c7
    3 N24e81d7674b24a019e470ee9f05e1851
    4 N47171a0543cf4f0fb4bee8dd74350710
    5 N4bbcc1686d774f1d874c5df633a359f6
    6 N6d7484cb0f3b49e4a452064663ea3afa
    7 N6def9d87249343ea91e3298771d0a81a
    8 N7864894e31df4d27b34f5d260cc10d2c
    9 N79f1af54ae7849fdbe1e056dd390ed3d
    10 N833fa9ac0523467f93903ad6a21339f9
    11 N8998f96ac0ce40659548a6f5ab9f93c4
    12 N9f41ab4034294871832ba408924f8a2a
    13 Nd7a8f694c6c8465a8e59632e715d1769
    14 Nd8619121b71d444695be298336cea16f
    15 Ne5af4aed35ec4a98bb94f6c83d719605
    16 Ne5c6133e69814b27a28cbba547a7ab9b
    17 Ne745c74678ff4ed78e5ef8660e405c75
    18 Ne8f04a44773c49bbaa2d188ed6e2d7a5
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 anzsrc-for:1108
    22 schema:author N8c57a3f7ae2c4a4db29fea946634a4fc
    23 schema:citation sg:pub.10.1007/978-1-4612-3900-0_4
    24 sg:pub.10.1007/bf02009383
    25 sg:pub.10.1038/289187a0
    26 sg:pub.10.1038/sj.bmt.1700752
    27 schema:datePublished 2001-02
    28 schema:datePublishedReg 2001-02-01
    29 schema:description Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295–300.
    30 schema:genre article
    31 schema:inLanguage en
    32 schema:isAccessibleForFree true
    33 schema:isPartOf N4920a63034a049d9af647ee257642b0e
    34 Ne2708403c5004d75bf0cff1d91d9993a
    35 sg:journal.1096890
    36 schema:keywords BMT recipients
    37 Bone Marrow Transplantation (2001) 27
    38 Diseases Unit
    39 Infectious Diseases Unit
    40 PIV3 infection
    41 PIV3 lower respiratory tract infection
    42 PIV3-positive hematological patients
    43 Transplantation (2001) 27
    44 adherence
    45 antigen detection
    46 chest radiographs
    47 cohorting
    48 commencement
    49 contact isolation precautions
    50 detection
    51 diagnostics
    52 disease
    53 early commencement
    54 education
    55 experience
    56 further education
    57 hematological malignancies
    58 hematological patients
    59 hematology unit
    60 high mortality rate
    61 hospital hygiene
    62 hygiene
    63 infection
    64 infiltrate
    65 intravenous ribavirin
    66 intravenous ribavirin therapy
    67 isolation precautions
    68 lower respiratory tract infections
    69 malignancy
    70 mortality
    71 mortality rate
    72 nasopharyngeal
    73 nasopharyngeal samples
    74 nosocomial origin
    75 nosocomial spread
    76 origin
    77 parainfluenza virus type 3
    78 parainfluenza virus type 3 infection
    79 patients
    80 period
    81 policy
    82 precautions
    83 radiographs
    84 rapid diagnostics
    85 rate
    86 recipients
    87 respiratory symptoms
    88 respiratory tract infections
    89 ribavirin
    90 ribavirin therapy
    91 samples
    92 spread
    93 spread of PIV3
    94 staff
    95 strict adherence
    96 symptoms
    97 systematic nasopharyngeal
    98 therapy
    99 tract infections
    100 type 3
    101 type 3 infection
    102 units
    103 virus type 3
    104 virus type 3 infections
    105 wards
    106 schema:name Parainfluenza virus type 3 infections in a hematology unit
    107 schema:pagination 295-300
    108 schema:productId N152a530ea4e64ec9ac9d13c47c3d7da1
    109 N256d3a4c662143b0b46f4cf687c2bb05
    110 N819bd86372b04b02abfe6443683b29c6
    111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026152219
    112 https://doi.org/10.1038/sj.bmt.1702776
    113 schema:sdDatePublished 2022-01-01T18:11
    114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    115 schema:sdPublisher Ncbc5da87736b440c8869efe19585bd9a
    116 schema:url https://doi.org/10.1038/sj.bmt.1702776
    117 sgo:license sg:explorer/license/
    118 sgo:sdDataset articles
    119 rdf:type schema:ScholarlyArticle
    120 N04034540a8e84a838204243af16166c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Hematology
    122 rdf:type schema:DefinedTerm
    123 N152a530ea4e64ec9ac9d13c47c3d7da1 schema:name pubmed_id
    124 schema:value 11277177
    125 rdf:type schema:PropertyValue
    126 N225fa1ff9e234c6788335c0b6dd39bbd rdf:first sg:person.01137767024.86
    127 rdf:rest rdf:nil
    128 N242fdc501c8747eeb01a37153c31c0c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Follow-Up Studies
    130 rdf:type schema:DefinedTerm
    131 N24e81d7674b24a019e470ee9f05e1851 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Antigens, Viral
    133 rdf:type schema:DefinedTerm
    134 N256d3a4c662143b0b46f4cf687c2bb05 schema:name doi
    135 schema:value 10.1038/sj.bmt.1702776
    136 rdf:type schema:PropertyValue
    137 N47171a0543cf4f0fb4bee8dd74350710 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Female
    139 rdf:type schema:DefinedTerm
    140 N4920a63034a049d9af647ee257642b0e schema:volumeNumber 27
    141 rdf:type schema:PublicationVolume
    142 N4bbcc1686d774f1d874c5df633a359f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Immunocompromised Host
    144 rdf:type schema:DefinedTerm
    145 N66cd9b12c3a146749fa21e777a458a42 rdf:first sg:person.0623450752.49
    146 rdf:rest Nf82066b2883f4aeda36256a0995696c5
    147 N6d7484cb0f3b49e4a452064663ea3afa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Hematologic Neoplasms
    149 rdf:type schema:DefinedTerm
    150 N6def9d87249343ea91e3298771d0a81a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Paramyxoviridae Infections
    152 rdf:type schema:DefinedTerm
    153 N7864894e31df4d27b34f5d260cc10d2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Hematopoietic Stem Cell Transplantation
    155 rdf:type schema:DefinedTerm
    156 N79f1af54ae7849fdbe1e056dd390ed3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Parainfluenza Virus 3, Human
    158 rdf:type schema:DefinedTerm
    159 N819bd86372b04b02abfe6443683b29c6 schema:name dimensions_id
    160 schema:value pub.1026152219
    161 rdf:type schema:PropertyValue
    162 N833fa9ac0523467f93903ad6a21339f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Middle Aged
    164 rdf:type schema:DefinedTerm
    165 N8998f96ac0ce40659548a6f5ab9f93c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Hospital Units
    167 rdf:type schema:DefinedTerm
    168 N8c57a3f7ae2c4a4db29fea946634a4fc rdf:first sg:person.01023540424.78
    169 rdf:rest N66cd9b12c3a146749fa21e777a458a42
    170 N9f41ab4034294871832ba408924f8a2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Aged
    172 rdf:type schema:DefinedTerm
    173 Na949e3b5df6541e6862f12a4c9fa44c2 rdf:first sg:person.0742670020.35
    174 rdf:rest Nf0ffe40587b349abade84bb5404b17ac
    175 Ncbc5da87736b440c8869efe19585bd9a schema:name Springer Nature - SN SciGraph project
    176 rdf:type schema:Organization
    177 Nd7a8f694c6c8465a8e59632e715d1769 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Male
    179 rdf:type schema:DefinedTerm
    180 Nd8619121b71d444695be298336cea16f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Cross Infection
    182 rdf:type schema:DefinedTerm
    183 Ne2708403c5004d75bf0cff1d91d9993a schema:issueNumber 3
    184 rdf:type schema:PublicationIssue
    185 Ne5af4aed35ec4a98bb94f6c83d719605 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Humans
    187 rdf:type schema:DefinedTerm
    188 Ne5c6133e69814b27a28cbba547a7ab9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Finland
    190 rdf:type schema:DefinedTerm
    191 Ne745c74678ff4ed78e5ef8660e405c75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Adult
    193 rdf:type schema:DefinedTerm
    194 Ne7cea28a03f7454fa0e782d028ebe96c rdf:first sg:person.01342274627.34
    195 rdf:rest Na949e3b5df6541e6862f12a4c9fa44c2
    196 Ne8f04a44773c49bbaa2d188ed6e2d7a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Ribavirin
    198 rdf:type schema:DefinedTerm
    199 Nf0ffe40587b349abade84bb5404b17ac rdf:first sg:person.01231423755.90
    200 rdf:rest N225fa1ff9e234c6788335c0b6dd39bbd
    201 Nf82066b2883f4aeda36256a0995696c5 rdf:first sg:person.0612620377.46
    202 rdf:rest Ne7cea28a03f7454fa0e782d028ebe96c
    203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    204 schema:name Medical and Health Sciences
    205 rdf:type schema:DefinedTerm
    206 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    207 schema:name Clinical Sciences
    208 rdf:type schema:DefinedTerm
    209 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    210 schema:name Medical Microbiology
    211 rdf:type schema:DefinedTerm
    212 sg:journal.1096890 schema:issn 0268-3369
    213 1476-5365
    214 schema:name Bone Marrow Transplantation
    215 schema:publisher Springer Nature
    216 rdf:type schema:Periodical
    217 sg:person.01023540424.78 schema:affiliation grid-institutes:grid.410552.7
    218 schema:familyName Hohenthal
    219 schema:givenName U
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023540424.78
    221 rdf:type schema:Person
    222 sg:person.01137767024.86 schema:affiliation grid-institutes:grid.410552.7
    223 schema:familyName Kotilainen
    224 schema:givenName P
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137767024.86
    226 rdf:type schema:Person
    227 sg:person.01231423755.90 schema:affiliation grid-institutes:grid.410552.7
    228 schema:familyName Itälä
    229 schema:givenName M
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423755.90
    231 rdf:type schema:Person
    232 sg:person.01342274627.34 schema:affiliation grid-institutes:grid.410552.7
    233 schema:familyName Peltonen
    234 schema:givenName R
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342274627.34
    236 rdf:type schema:Person
    237 sg:person.0612620377.46 schema:affiliation grid-institutes:grid.1374.1
    238 schema:familyName Vainionpää
    239 schema:givenName R
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612620377.46
    241 rdf:type schema:Person
    242 sg:person.0623450752.49 schema:affiliation grid-institutes:grid.410552.7
    243 schema:familyName Nikoskelainen
    244 schema:givenName J
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623450752.49
    246 rdf:type schema:Person
    247 sg:person.0742670020.35 schema:affiliation grid-institutes:grid.410552.7
    248 schema:familyName Routamaa
    249 schema:givenName M
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742670020.35
    251 rdf:type schema:Person
    252 sg:pub.10.1007/978-1-4612-3900-0_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016607238
    253 https://doi.org/10.1007/978-1-4612-3900-0_4
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1007/bf02009383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013894701
    256 https://doi.org/10.1007/bf02009383
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1038/289187a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038585061
    259 https://doi.org/10.1038/289187a0
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1038/sj.bmt.1700752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017083491
    262 https://doi.org/10.1038/sj.bmt.1700752
    263 rdf:type schema:CreativeWork
    264 grid-institutes:grid.1374.1 schema:alternateName Department of Virology, Turku University, Turku, Finland
    265 schema:name Department of Virology, Turku University, Turku, Finland
    266 rdf:type schema:Organization
    267 grid-institutes:grid.410552.7 schema:alternateName Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland
    268 Department of Surgery, Turku University Central Hospital, Turku, Finland
    269 schema:name Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland
    270 Department of Surgery, Turku University Central Hospital, Turku, Finland
    271 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...